Bronchoalveolar Fluid and Plasma Inflammatory Biomarkers in Contemporary ARDS Patients

PURPOSE: Bronchoalveolar fluid (BALF) and plasma biomarkers are often endpoints in early phase randomized trials (RCTs) in acute respiratory distress syndrome (ARDS). With ARDS mortality decreasing, we analyzed baseline biomarkers in samples from contemporary ARDS patients participating in a prior R...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomarkers
Autors principals: Stapleton, Renee D., Suratt, Benjamin T., Neff, Margaret J., Wurfel, Mark M., Ware, Lorraine B., Ruzinski, John T., Caldwell, Ellen, Hallstrand, Teal S., Parsons, Polly E.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147943/
https://ncbi.nlm.nih.gov/pubmed/30744430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/1354750X.2019.1581840
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars